Vahid Mohsenin

Dr. Vahid Mohsenin

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2009 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
NSNeomi A. Shah
Neomi A. Shah
HYHenry Klar Yaggi
Henry Klar Yaggi
JCJohn Concato
John Concato
VMVahid Mohsenin
Vahid Mohsenin

1 November 2001 in Chest
Verified
Journal Article
Closed access
PDF file
VMVahid Mohsenin
Vahid Mohsenin

1 January 1999 in Chest
Verified
Journal Article
Open access
PDF file
CDCarolyn D’ambrosio
Carolyn D’ambrosio
TBTeri Bowman
Teri Bowman
VMVahid Mohsenin
Vahid Mohsenin
Quality of Life in Patients with Obstructive Sleep Apnea: Effect of Nasal Continuous Positive Airway Pressure—A Prospective Study

1 June 2015 in Pulmonary Circulation
Verified
Journal Article
Open access
CKCyrus Kholdani
Cyrus Kholdani
WFWassim H. Fares
Wassim H. Fares
VMVahid Mohsenin
Vahid Mohsenin
The development of pulmonary hypertension is a poor prognostic sign in patients with obstructive sleep apnea (OSA) and affects both mortality and quality of life. Although pulmonary hypertension in OSA is traditionally viewed as a result of apneas and intermittent hypoxia during sleep, recent studies indicate that neither of these factors correlates very well with pulmonary artery pressure. Human data show that pulmonary hypertension in the setting of OSA is, in large part, due to left heart dysfunction with either preserved or diminished ejection fraction. Longstanding increased left heart filling pressures eventually lead to pulmonary venous hypertension. The combination of hypoxic pulmonary vasoconstriction and pulmonary venous hypertension with abnormal production of mediators will result in vascular cell proliferation and aberrant vascular remodeling leading to pulmonary hypertension. These changes are in many ways similar to those seen in other forms of pulmonary hypertension and suggest shared mechanisms. The majority of patients with OSA do not receive a diagnosis and are undertreated. Appreciating the high prevalence and understanding the mechanisms of pulmonary hypertension in OSA would lead to better recognition and management of the condition.


BKBruce Kirenga
Bruce Kirenga
QMQingyu Meng
Qingyu Meng
FGFrederik Van Gemert
Frederik Van Gemert
HAHellen Aanyu-Tukamuhebwa
Hellen Aanyu-Tukamuhebwa
NCNiels Chavannes
Niels Chavannes
VMVahid Mohsenin
Vahid Mohsenin
Air pollution is one of the leading global public health risks but its magnitude in many developing countries’ cities is not known. We aimed to measure the concentration of particulate matter with aerodynamic diameter <2.5 µm (PM2.5), nitrogen dioxide (NO2), sulfur dioxide (SO2), and ozone (O3) pollutants in two Ugandan cities (Kampala and Jinja). PM2.5, O3, temperature and humidity were measured with real-time monitors, while NO2 and SO2 were measured with diffusion tubes. We found that the mean concentrations of the air pollutants PM2.5, NO2, SO2 and O3 were 132.1 μg/m3, 24.9 µg/m3, 3.7 µg/m3 and 11.4 μg/m3, respectively. The mean PM2.5 concentration is 5.3 times the World Health Organization (WHO) cut-off limits while the NO2, SO2 and O3 concentrations are below WHO cut-off limits. PM2.5 levels were higher in Kampala than in Jinja (138.6 μg/m3 vs. 99.3 μg/m3) and at industrial than residential sites (152.6 μg/m3 vs. 120.5 μg/m3) but residential sites with unpaved roads also had high PM2.5 concentrations (152.6 μg/m3). In conclusion, air pollutant concentrations in Kampala and Jinja in Uganda are dangerously high. Long-term studies are needed to characterize air pollution levels during all seasons, to assess related public health impacts, and explore mitigation approaches.